Description
This Notice of Funding Opportunity (NOFO) is for a Limited Competition that will invite applications from eligible organizations to apply for research on liver cirrhosis. The purpose of this NOFO is to complete the enrollment in both the Liver Cirrhosis Network Longitudinal Cohort Study and the Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): A Double-Blind Randomized, Placebo-Controlled Phase 2 Study. The Liver Cirrhosis Network will perform data analyses, disseminate findings, and perform ancillary analyses.
Key aspects of this opportunity include:
• The application of a U01 cooperative agreement activity code
• The encouragement of collaborative investigations combining expertise in translational sciences
• The requirement for recipients to adhere to the Data Management and Sharing requirements as outlined in the NIH Grants Policy Statement
• The establishment of a Steering Committee to govern the study and make major scientific decisions
• The composition of the Steering Committee, including all Program Director(s)/Principal Investigator(s) and the NIDDK Project Scientist or Project Coordinator